Sinew Pharma (ROCO:6634) Accounts Payable & Accrued Expense : NT$14.42 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Accounts Payable & Accrued Expense?

Sinew Pharma's quarterly accounts payable & accrued expense increased from Jun. 2022 (NT$12.66 Mil) to Dec. 2022 (NT$19.17 Mil) but then declined from Dec. 2022 (NT$19.17 Mil) to Jun. 2023 (NT$14.42 Mil).

Sinew Pharma's annual accounts payable & accrued expense declined from Dec. 2020 (NT$12.92 Mil) to Dec. 2021 (NT$12.72 Mil) but then increased from Dec. 2021 (NT$12.72 Mil) to Dec. 2022 (NT$19.17 Mil).

Sinew Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sinew Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Accounts Payable & Accrued Expense Chart

Sinew Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11.81

10.65

12.92

12.72

19.17

Sinew Pharma Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial												7.33	12.72	12.66	19.17	14.42

Sinew Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sinew Pharma (ROCO:6634) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571

Website

https://www.sinewpharma.com

Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines